Click to Visit
  高级搜索
立即登录 | 免费注册
当前位置: 首页 (内分泌学与糖尿病) > 医药资讯 >  药品动态  > 药讯速递
Module Load Warning
One or more of the modules on this page did not load. This may be temporary. Please refresh the page (click F5 in most browsers). If the problem persists, please let the know.

EPMI_DrugNews_NewDrugs_Latest
标题 时间 阅读
数量
评论
数量
罗氏/ 益普生暂停研发的Taspoglutide可能成为又一...
Roche/Ipsen's Suspended Taspoglutide Could Become Another Di...
2010-09-14 241 0
北京公司启动糖尿病干细胞治疗临床试验
Beijing Firm Launches Clinical Trial On Stem Cell Treatment ...
2010-08-24 180 0
生物疗法治疗糖尿病足溃疡有效,但常被推迟应用
Advanced Biologic Therapies for Diabetic Foot Ulcers Effecti...
2010-08-18 29 0
减肥药的安全性战胜疗效
For Obesity Drugs, Safety Trumps Efficacy
2010-08-18 123 0
新型速效胰岛素的低血糖事件更少且体重增幅更小
Novel Rapid-Acting Insulin Associated With Less Hypoglycemia...
2010-08-18 97 0
植入式抗生素海绵未能降低手术伤口感染的发生率
Implantable Antibiotic Sponge Fails to Reduce Surgical Wound...
2010-08-17 23 0
早期试验显示,试验用超长效胰岛素类似物安全有效
Investigational Ultra–Long-Acting Insulin Analogue Effective...
2010-08-05 244 0
模拟随机研究:“银”标准?
Go for the Silver? Using Simulated Randomized Trials
2010-08-03 105 0
他喷他多缓释制剂可有效治疗慢性神经源性及伤害性疼痛
Tapentadol ER Effective for Chronic Neuropathic, Nociceptive...
2010-07-26 156 0
减肥药西布曲明未通过安全性试验
Weight-Loss Drug Sibutramine Fails Safety Trial
2010-07-26 132 0
凡德他尼可延缓甲状腺髓样癌进展
Vandetanib Stalls Progression of Metastatic Medullary Thyroi...
2010-07-15 159 0
新型药物可降低经二甲双胍治疗的2型糖尿病患者的HbA1c
Novel Drug Reduces HbA1c in Type 2 Diabetes Patients on Metf...
2010-07-06 130 0
每周1次艾塞那肽比每日1次甘精胰岛素能更大程度地降低HbA1...
Once-Weekly Exenatide Lowers HbA1c More Than Exenatide Daily...
2010-07-06 114 0
减重并非睡眠呼吸暂停综合征治疗的唯一靶点
Weight Loss Not the Only Target in Sleep Apnea Pipeline
2010-07-06 68 0
EMA增补依西奈肽和HPV疫苗的适应证
EMA Adds Indications for Exenatide, HPV Vaccine
2010-07-06 114 0
Taspoglutide可控制血糖水平,但会引起胃肠道不良反...
Taspoglutide Controlled Glucose Levels, But Caused GI Side E...
2010-07-06 79 0
NICE将扩大儿童中生长激素的治疗适应证
NICE Expands Use of Growth Hormone in Children
2010-05-26 82 0
GLP-1能否获批将于今年秋季见分晓:Bydureon新一轮...
GLP-1 Showdown Set For Fall: Bydureon Gets New October Revie...
2010-05-10 354 0
诺和诺德GLP-1类似物Victoza赢得开门红
Novo Nordisk's GLP-1 Victoza Off To A Good Start
2010-04-29 621 1
维生素E、吡格列酮可改善非酒精性脂肪肝炎
Vitamin E, Pioglitazone May Improve Nonalcoholic Steatohepat...
2010-04-28 184 0
EPMI_DrugNews_NewDrugs_Read
标题 时间 阅读
数量
评论
数量
FDA批准Onglyza用于2型糖尿病
FDA approves Onglyza for type 2 diabetes
2009-08-07 1283 0
FDA批准Byetta注射剂单药治疗2型糖尿病
FDA approves injectable Byetta as monotherapy for type 2 dia...
2009-11-04 1011 0
速效胰岛素Novolog的最新说明书允许在胰岛素泵内的储存时...
Updated label for fast-acting insulin Novolog allows for lon...
2009-07-23 862 0
甲氧氯普胺速溶片剂获美国FDA批准
Fast-dissolve tablet version of metoclopramide receives FDA ...
2009-09-10 813 0
糖尿病复方缓释药物Actoplus Met XR获得FDA批...
Extended-release diabetic combo drug Actoplus Met XR receive...
2009-06-12 725 0
诺和诺德GLP-1类似物Victoza赢得开门红
Novo Nordisk's GLP-1 Victoza Off To A Good Start
2010-04-29 621 1
FDA批准注射用Victoza用于治疗2型糖尿病
FDA approves injectable Victoza for type 2 diabetes
2010-01-28 557 0
FDA批准一次性的预充式胰岛素笔,用以控制成人及4岁和4岁以...
Prefilled disposable insulin pen approved by FDA for glycemi...
2009-03-02 544 0
FDA专家组将权衡胰岛素泵上市后的安全性及治疗失败风险
FDA Panel To Weigh Insulin Pump Post-Market Safety, Failure ...
2010-03-08 533 0
研究中的胰岛素增敏剂疗效显著,且不会增加体重
Investigational Insulin Sensitizer Appears Effective Without...
2009-07-08 500 0
研究二甲双胍用于抗癌治疗的可能性
Metformin Being Investigated as Possible Anticancer Treatmen...
2009-10-01 495 0
降胆固醇药考来维仑现已获准用于治疗某些儿科患者
Cholesterol drug Welchol now approved for some pediatric pat...
2009-10-16 483 0
“膳食补充剂”因疑似含有类固醇而被召回
Suspicion of steroids in some 'dietary supplements' prompts ...
2009-11-09 413 0
FDA批准新型2型糖尿病治疗药物Cycloset
FDA approves new type 2 diabetes drug Cycloset
2009-06-12 405 0
Reclast已获准用于预防及治疗骨质疏松症
Reclast now approved to prevent as well as treat osteoporosi...
2009-06-12 399 0
两种减肥药在III期试验中初显潜力
Two Obesity Drugs Show Promise in Phase III Trials
2009-10-27 381 0
GLP-1能否获批将于今年秋季见分晓:Bydureon新一轮...
GLP-1 Showdown Set For Fall: Bydureon Gets New October Revie...
2010-05-10 354 0
治疗糖尿病、脂肪肝病变的新药正在研究中
New Drug Under Study for Treatment of Diabetes, Fatty Liver ...
2009-10-20 348 0
试验药物应用56周后减肥效果显著
Investigational Agent Leads to Significant Weight Loss at 56...
2009-06-25 347 0
前瞻性研究显示,应用二甲双胍可降低癌症病死率
Metformin Use Protective Against Cancer Mortality in Prospec...
2009-12-02 334 0
EPMI_DrugNews_NewDrugs_Comment
标题 时间 阅读
数量
评论
数量
诺和诺德GLP-1类似物Victoza赢得开门红
Novo Nordisk's GLP-1 Victoza Off To A Good Start
2010-04-29 621 1
金纳米粒子载体用于逆转小鼠1型糖尿病
Gold Nanoparticle Vector Used to Reverse Type 1 Diabetes in ...
2010-04-16 184 0
有望用于治疗肝病的试验性药物
Investigational Drug Holds Potential for Treatment of Liver ...
2010-04-21 138 0
维生素E、吡格列酮可改善非酒精性脂肪肝炎
Vitamin E, Pioglitazone May Improve Nonalcoholic Steatohepat...
2010-04-28 184 0
GLP-1能否获批将于今年秋季见分晓:Bydureon新一轮...
GLP-1 Showdown Set For Fall: Bydureon Gets New October Revie...
2010-05-10 354 0
NICE将扩大儿童中生长激素的治疗适应证
NICE Expands Use of Growth Hormone in Children
2010-05-26 82 0
新型药物可降低经二甲双胍治疗的2型糖尿病患者的HbA1c
Novel Drug Reduces HbA1c in Type 2 Diabetes Patients on Metf...
2010-07-06 130 0
每周1次艾塞那肽比每日1次甘精胰岛素能更大程度地降低HbA1...
Once-Weekly Exenatide Lowers HbA1c More Than Exenatide Daily...
2010-07-06 114 0
减重并非睡眠呼吸暂停综合征治疗的唯一靶点
Weight Loss Not the Only Target in Sleep Apnea Pipeline
2010-07-06 68 0
EMA增补依西奈肽和HPV疫苗的适应证
EMA Adds Indications for Exenatide, HPV Vaccine
2010-07-06 114 0
Taspoglutide可控制血糖水平,但会引起胃肠道不良反...
Taspoglutide Controlled Glucose Levels, But Caused GI Side E...
2010-07-06 79 0
凡德他尼可延缓甲状腺髓样癌进展
Vandetanib Stalls Progression of Metastatic Medullary Thyroi...
2010-07-15 159 0
他喷他多缓释制剂可有效治疗慢性神经源性及伤害性疼痛
Tapentadol ER Effective for Chronic Neuropathic, Nociceptive...
2010-07-26 156 0
减肥药西布曲明未通过安全性试验
Weight-Loss Drug Sibutramine Fails Safety Trial
2010-07-26 132 0
模拟随机研究:“银”标准?
Go for the Silver? Using Simulated Randomized Trials
2010-08-03 105 0
早期试验显示,试验用超长效胰岛素类似物安全有效
Investigational Ultra–Long-Acting Insulin Analogue Effective...
2010-08-05 244 0
减肥药的安全性战胜疗效
For Obesity Drugs, Safety Trumps Efficacy
2010-08-18 123 0
新型速效胰岛素的低血糖事件更少且体重增幅更小
Novel Rapid-Acting Insulin Associated With Less Hypoglycemia...
2010-08-18 97 0
北京公司启动糖尿病干细胞治疗临床试验
Beijing Firm Launches Clinical Trial On Stem Cell Treatment ...
2010-08-24 180 0
罗氏/ 益普生暂停研发的Taspoglutide可能成为又一...
Roche/Ipsen's Suspended Taspoglutide Could Become Another Di...
2010-09-14 241 0

病例分析  病例分析

 曹晶珠  邹大进

解放军第二军医大学附属长海医院内分泌科

 

患者为青年男性,21岁,因反复四肢无力5年余2009年入院。患者4年前因四肢无力,就诊于上海市某医院,查血钾1.9 mmol/L,醛固酮176.05 pg/ml,双侧肾上腺正常,考虑“高醛固酮血症”,予补钾治疗后好转。后因仍反复发作四肢无力,2007年就诊上海另一家医院,查右肾GFR轻度下降,基础血浆肾素活性10 ng/(ml·h),基础醛固酮314 pg/ml,诊断为“巴特综合征(血压正常性醛固酮增多)”,予安体舒通、补钾、消炎痛栓、雷米普利等治疗,出院后消炎痛栓、雷米普利使用2周后停药。因服安体舒通30 mg3/日,出现乳腺增生,减为10 mg 3/日,服药期间仍反复出现四肢无力。2008年在我院治疗,予碳酸氢钠、门冬氨酸钾镁、复方枸橼酸钾、氯化钾缓释片、拜堂苹、安体舒通等治疗,出院诊断为“巴特综合征、肾小管酸中毒、糖耐量异常(高胰岛素血症)”,出院后坚持口服上述药物,定期监测血钾波动于3.14.0 mmol/L,无四肢无力发作。1周前复查血钾3.0 mmol/L。既往史、个人史、家族史均无特殊。

医学数据库  医学数据库



友情链接:中文版柳叶刀 | MD CONSULT | Journals CONSULT | Procedures CONSULT | eClips CONSULT | Imaging CONSULT | 论文吧 | 世界医学书库 | 医心网 | 前沿医学资讯网

公司简介 | 用户协议 | 条件与条款 | 隐私权政策 | 网站地图 | 联系我们

 互联网药品信息服务资格证书 | 卫生局审核意见通知书 | 药监局行政许可决定书 
电信与信息服务业务经营许可证 | 京ICP证070259号 | 京ICP备09068478号

Copyright © 2009 Elsevier. All Rights Reserved.爱思唯尔版权所有